Last reviewed · How we verify

NCT05461872

Retrospective Review on PAEDIATRIC and ADOLESCENT ADNEXAL MASSES

Status unknown Last updated 15 August 2022
What this trial tests

trial testing No intervention in Adnexal Mass in 300 participants. Status unknown.

Timeline
12 August 2022
Primary endpoint
31 December 2023
31 December 2023

Quick facts

Lead sponsorChinese University of Hong Kong
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment300
Start date12 August 2022
Primary completion31 December 2023
Estimated completion31 December 2023
Sites1 location across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

Chinese University of Hong Kong

Who can join

Adults 1 Day to 21, female only, with Adnexal Mass. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To review the characteristic, presentation and outcome of girls presented with adnexal masses to hopefully develop a management algorithm for girls with adnexal masses.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Adnexal Mass

Currently open trials in the same condition.

Other Chinese University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05461872.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing